Medexus Pharmaceuticals Stock Analysis
| MEDXF Stock | USD 1.96 0.05 2.49% |
Medexus Pharmaceuticals is overvalued with Real Value of 1.77 and Hype Value of 1.96. The main objective of Medexus Pharmaceuticals otc analysis is to determine its intrinsic value, which is an estimate of what Medexus Pharmaceuticals is worth, separate from its market price. There are two main types of Medexus Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The Medexus Pharmaceuticals otc stock is traded in the USA on OTCQX Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Medexus Pharmaceuticals' ongoing operational relationships across important fundamental and technical indicators.
Medexus |
Medexus OTC Stock Analysis Notes
The company has price-to-book ratio of 1.75. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medexus Pharmaceuticals last dividend was issued on the 19th of December 2018. The entity had 1:15 split on the 19th of December 2018. Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.The quote for Medexus Pharmaceuticals is listed on Over The Counter exchange (i.e., OTC), and the entity is not required to meet listing requirements such as those found on the Nasdaq, NYSE, or AMEX exchanges. To find out more about Medexus Pharmaceuticals contact Kenneth dEntremont at 877 633 3987 or learn more at https://www.medexus.com.Medexus Pharmaceuticals Investment Alerts
| Medexus Pharmaceuticals may become a speculative penny stock | |
| Medexus Pharmaceuticals has high likelihood to experience some financial distress in the next 2 years | |
| Medexus Pharmaceuticals has accumulated 39.82 M in total debt with debt to equity ratio (D/E) of 3.27, implying the company greatly relies on financing operations through barrowing. Medexus Pharmaceuticals has a current ratio of 0.95, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist Medexus Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, Medexus Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medexus Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medexus to invest in growth at high rates of return. When we think about Medexus Pharmaceuticals' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 76.7 M. Net Loss for the year was (2.88 M) with profit before overhead, payroll, taxes, and interest of 43.67 M. | |
| Medexus Pharmaceuticals has accumulated about 7.29 M in cash with (1.18 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.37. |
Medexus Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 23.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medexus Pharmaceuticals's market, we take the total number of its shares issued and multiply it by Medexus Pharmaceuticals's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Medexus Profitablity
Medexus Pharmaceuticals' profitability indicators refer to fundamental financial ratios that showcase Medexus Pharmaceuticals' ability to generate income relative to its revenue or operating costs. If, let's say, Medexus Pharmaceuticals is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Medexus Pharmaceuticals' executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Medexus Pharmaceuticals' profitability requires more research than a typical breakdown of Medexus Pharmaceuticals' financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.05 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.05. Technical Drivers
As of the 23rd of July, Medexus Pharmaceuticals secures the Risk Adjusted Performance of 0.0988, downside deviation of 2.96, and Mean Deviation of 2.18. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medexus Pharmaceuticals, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Medexus Pharmaceuticals, which can be compared to its peers in the industry. Please verify Medexus Pharmaceuticals treynor ratio, and the relationship between the standard deviation and downside variance to decide if Medexus Pharmaceuticals is priced some-what accurately, providing market reflects its recent price of 1.96 per share. Please also check out Medexus Pharmaceuticals total risk alpha, which is currently at (0.27) to check the company can sustain itself at a future point.Medexus Pharmaceuticals Price Movement Analysis
The output start index for this execution was eight with a total number of output elements of fifty-three. The Simple Moving Average indicator is calculated by adding the closing price of Medexus Pharmaceuticals for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Medexus Pharmaceuticals short-term fluctuations and highlight longer-term trends or cycles.
Medexus Pharmaceuticals Predictive Daily Indicators
Medexus Pharmaceuticals intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medexus Pharmaceuticals otc stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Medexus Pharmaceuticals Forecast Models
Medexus Pharmaceuticals' time-series forecasting models are one of many Medexus Pharmaceuticals' otc stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medexus Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Medexus OTC Stock Analysis
OTC Stock analysis is the technique used by a trader or investor to examine and evaluate how Medexus Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medexus shares will generate the highest return on investment. We also built our otc analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual OTC such as Medexus Pharmaceuticals. By using and applying Medexus OTC Stock analysis, traders can create a robust methodology for identifying Medexus entry and exit points for their positions.
Medexus Pharmaceuticals Inc. operates as a specialty pharmaceutical company in Canada and the United States. The company was formerly known as Pediapharm Inc. and changed its name to Medexus Pharmaceuticals Inc. in December 2018. Medexus Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 100 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our otc stock analysis tools, you can find out how much better you can do when adding Medexus Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Risk-Return Analysis Now
Risk-Return AnalysisView associations between returns expected from investment and the risk you assume |
| All Next | Launch Module |
Complementary Tools for Medexus OTC Stock analysis
When running Medexus Pharmaceuticals' price analysis, check to measure Medexus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medexus Pharmaceuticals is operating at the current time. Most of Medexus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Medexus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medexus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Medexus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Stocks Directory Find actively traded stocks across global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |